We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker; Dr. Diana Rafael, main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) VHIR
Abstract: The constant development of new synthetic drug delivery systems in the last years have been highly contributing to the advancement of new treatments for a wide-range of challenging diseases, for which the conventional treatments are not efficient. The use of nanoparticles and hydrogels have been a breakthrough in clinical application, with hundreds of new products enrolling clinical trials and being approved in the clinical practice. In the CB-DDT group we are experts in the development of new therapeutic strategies based on nanoparticles and hydrogels for several different clinical applications. This presentation will be divided in two parts: The first one dedicated to the most promising works regarding the development of nanoparticles encapsulating different drugs and biomolecules for the systemic treatment of different pathological conditions, and the second one dedicated to the most promising results regarding the use of biodegradable, smart hydrogels for cancer local treatment.
Bio Sketch: Diana Rafael, is a Principal Investigator at VHIR. She has a PhD in Pharmaceutical Technology (2017), and since 2013 she has been associated with the Clinical Biochemistry: Drug Delivery and Therapy Group from VHIR, where she initiated a research line dedicated to the production and characterization of Delivery Systems. Diana participated in more than 12 highly competitive national and international research projects and her research work originated 2 patents and more than 40 peer-reviewed publications. This year, Diana was granted with a Global Marie Sk³odowska-Curie Postdoctoral Fellowship and a Grant from the Spanish Association against the Pancreatic Cancer. Moreover, since January Diana has been implementing a new section within the FVPR/U20 platform of the Nanbiosis, certified by ISO9001:2015, dedicated to the synthesis and characterization of Nanosystems.
Host: Dr. Ibane Abasolo, head of group Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) VHIR
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.